Preferred Label : Mometasone Furoate;

MeSH definition : A pregnadienediol derivative ANTI-ALLERGIC AGENT and ANTI-INFLAMMATORY AGENT that is used in the management of ASTHMA and ALLERGIC RHINITIS. It is also used as a topical treatment for skin disorders.;

MeSH synonym : Furoate, Mometasone;

DeCS synonym : Asmanex Twisthaler;

MeSH Hyperonym : mometasone;

MeSH hyponym : Asmanex; nasonex; sch 32088; rinelon; mometasone furoate monohydrate; elocon; Furoate Monohydrate, Mometasone; Monohydrate, Mometasone Furoate; Twisthaler, Asmanex; Sch-32088; Sch32088;

CISMeF hyponym : Asmanex Twisthaler;

MeSH Related Number : 83919-23-7; 8HR4QJ6DW8; MTW0WEG809;

Is substance : O;

UNII : 04201GDN4R;

Details


Main resources

You can consult :

A pregnadienediol derivative ANTI-ALLERGIC AGENT and ANTI-INFLAMMATORY AGENT that is used in the management of ASTHMA and ALLERGIC RHINITIS. It is also used as a topical treatment for skin disorders.

https://www.has-sante.fr/jcms/p_3503148/fr/propel-contour
2024
France
health technology assessment
Implant
mometasone furoate
Mometasone Furoate
prostheses and implants
Administration via Implantation
implant, nos
Implant Dosing Unit
Implant Dosage Form
Implant Device Component
Contour
Implant Dosage Form Category
Mometasone Furoate

---
https://www.has-sante.fr/jcms/p_3503163/fr/propel-mini
2024
France
health technology assessment
Administration via Implantation
Implant Dosage Form Category
Mometasone Furoate
Implant Dosage Form
prostheses and implants
Implant
Implant Device Component
mometasone furoate
Implant Dosing Unit
Mometasone Furoate
implant, nos

---
https://www.has-sante.fr/jcms/p_3501896/fr/propel
2024
France
health technology assessment
Mometasone Furoate
Implant Device Component
Implant Dosage Form Category
Administration via Implantation
Implant Dosing Unit
Mometasone Furoate
Implant
prostheses and implants
mometasone furoate
implant, nos
Implant Dosage Form

---
https://www.has-sante.fr/jcms/p_3364928/fr/ryaltris-chlorhydrate-d-olopatadine/-furoate-de-mome-tasone-rhinite-allergique
2022
false
false
false
France
insurance, health, reimbursement
treatment outcome
drug combinations
Mometasone Furoate
adult
adolescent
Rhinitis, Allergic
nasal sprays
administration, intranasal
Olopatadine Hydrochloride
anti-allergic agents
histamine H1 antagonists, non-sedating
anti-inflammatory agents, non-steroidal
anti-inflammatory agents
evaluation of the transparency committee

---
https://www.has-sante.fr/jcms/p_3227239/fr/atectura-breezhaler
2021
false
false
false
France
treatment outcome
insurance, health, reimbursement
indacaterol and mometasone
drug combinations
administration, inhalation
indacaterol
adrenergic beta-2 receptor agonists
Mometasone Furoate
anti-inflammatory agents
asthma
adult
adolescent
evaluation of the transparency committee

---
https://www.has-sante.fr/jcms/p_3242947/fr/enerzair-breezhaler
2021
false
false
false
France
insurance, health, reimbursement
treatment outcome
drug combinations
administration, inhalation
indacaterol, glycopyrronium bromide and mometasone
Mometasone Furoate
indacaterol
adrenergic beta-2 receptor agonists
muscarinic antagonists
anti-inflammatory agents
guidelines for drug use
adult
asthma
evaluation of the transparency committee
glycopyrrolate
indans
quinolones

---
https://www.inesss.qc.ca/thematiques/medicaments/medicaments-evaluation-aux-fins-dinscription/extrait-davis-au-ministre/enerzair-breezhaler-5428.html
2020
false
false
false
Canada
French
asthma
drug combinations
administration, inhalation
drug evaluation
Mometasone Furoate
indacaterol
indacaterol, glycopyrronium bromide and mometasone
glycopyrrolate
indans
quinolones

---
https://www.inesss.qc.ca/thematiques/medicaments/medicaments-evaluation-aux-fins-dinscription/extrait-davis-au-ministre/atectura-breezhaler-5427.html
2020
false
false
false
Canada
French
drug evaluation
indacaterol and mometasone
drug combinations
administration, inhalation
asthma
indacaterol
Mometasone Furoate
indans
quinolones

---
https://www.has-sante.fr/jcms/p_3215558/fr/enerzair-breezhaler
2020
false
false
false
France
treatment outcome
insurance, health, reimbursement
drug combinations
administration, inhalation
Mometasone Furoate
indacaterol
adrenergic beta-2 receptor agonists
muscarinic antagonists
anti-inflammatory agents
indacaterol, glycopyrronium bromide and mometasone
asthma
adult
bronchodilator agents
evaluation of the transparency committee
glycopyrrolate
indans
quinolones

---
https://www.ema.europa.eu/en/medicines/human/EPAR/zimbus-breezhaler
2020
false
false
false
United Kingdom
French
English
treatment outcome
syndication feed
summary of product characteristics
package leaflet
drug evaluation
drug approval
europe
administration, inhalation
drug combinations
glycopyrrolate
glycopyrrolate
muscarinic antagonists
muscarinic antagonists
indacaterol
indacaterol
adrenergic beta-2 receptor agonists
adrenergic beta-2 receptor agonists
Mometasone Furoate
Mometasone Furoate
anti-inflammatory agents
anti-inflammatory agents
asthma
adult
aged
drug interactions
pregnancy
breast feeding
indacaterol, glycopyrronium bromide and mometasone
drug evaluation, preclinical
indans
quinolones
indans
quinolones

---
https://www.ema.europa.eu/en/medicines/human/EPAR/atectura-breezhaler
2020
false
false
false
United Kingdom
French
English
treatment outcome
syndication feed
summary of product characteristics
package leaflet
drug evaluation
drug approval
europe
drug combinations
indacaterol
indacaterol
adrenergic beta-2 receptor agonists
adrenergic beta-2 receptor agonists
indacaterol and mometasone
mometasone
mometasone
anti-inflammatory agents
anti-inflammatory agents
bronchodilator agents
bronchodilator agents
adult
adolescent
asthma
administration, inhalation
drug interactions
pregnancy
breast feeding
drug evaluation, preclinical
Mometasone Furoate
Mometasone Furoate
indans
quinolones
indans
quinolones

---
https://www.ema.europa.eu/en/medicines/human/EPAR/bemrist-breezhaler
2020
false
false
false
United Kingdom
French
English
treatment outcome
syndication feed
summary of product characteristics
package leaflet
drug evaluation
drug approval
europe
drug combinations
administration, inhalation
indacaterol
indacaterol
adrenergic beta-2 receptor agonists
adrenergic beta-2 receptor agonists
bronchodilator agents
bronchodilator agents
mometasone
mometasone
anti-inflammatory agents
anti-inflammatory agents
indacaterol and mometasone
adult
adolescent
asthma
drug interactions
pregnancy
breast feeding
drug evaluation, preclinical
Mometasone Furoate
Mometasone Furoate
indans
quinolones
indans
quinolones

---
https://www.ema.europa.eu/en/medicines/human/EPAR/enerzair-breezhaler
2020
false
false
false
United Kingdom
French
English
treatment outcome
syndication feed
summary of product characteristics
package leaflet
drug evaluation
drug approval
europe
drug combinations
indacaterol
indacaterol
indacaterol, glycopyrronium bromide and mometasone
adrenergic beta-2 receptor agonists
adrenergic beta-2 receptor agonists
muscarinic antagonists
muscarinic antagonists
Mometasone Furoate
Mometasone Furoate
administration, inhalation
asthma
adult
anti-inflammatory agents
anti-inflammatory agents
drug interactions
pregnancy
breast feeding
drug evaluation, preclinical
glycopyrrolate
glycopyrrolate
indans
quinolones
indans
quinolones

---
https://www.has-sante.fr/portail/jcms/c_2819909/fr/asmanex-twisthaler
2018
false
false
false
false
France
French
evaluation of the transparency committee
Asmanex Twisthaler
mometasone
Mometasone Furoate

---
http://www.has-sante.fr/portail/jcms/c_2747016/fr/nasonex
2017
false
false
France
French
evaluation of the transparency committee
corticosteroid therapy
Mometasone Furoate
rhinitis, allergic, seasonal
rhinitis, allergic, perennial
nasal polyps
treatment outcome
anti-allergic agents
mometasone furoate monohydrate
mometasone
anti-inflammatory agents
insurance, health, reimbursement
adult
adolescent
child
nasal sprays
administration, intranasal

---
http://www.has-sante.fr/portail/jcms/c_1283974/nasonex
http://www.has-sante.fr/portail/upload/docs/application/pdf/2012-08/nasonex_18072012_avis_ct12208.pdf
http://www.has-sante.fr/portail/jcms/c_539613/nasonex
http://www.has-sante.fr/portail/jcms/c_400668/nasonex-50-microgrammes/dose-suspension-pour-pulverisation-nasale-flacon-de-120-doses-code-cip-343-012-6
http://www.has-sante.fr/portail/jcms/c_399576/nasonex-50-g/dose-suspension-pour-pulverisation-nasale-flacon-de-120-doses
2012
false
France
French
evaluation of the transparency committee
corticosteroid therapy
Mometasone Furoate
rhinitis, allergic, seasonal
rhinitis, allergic, perennial
nasal polyps
treatment outcome
anti-allergic agents
mometasone furoate monohydrate
mometasone
anti-inflammatory agents
insurance, health, reimbursement
adult
adolescent
child
nasal sprays
administration, intranasal

---
http://www.has-sante.fr/portail/jcms/c_1234513/asmanex
http://www.has-sante.fr/portail/upload/docs/application/pdf/2012-04/asmanex_twisthaler_29022012_avis_ct11679.pdf
2012
false
France
French
evaluation of the transparency committee
corticosteroid therapy
Mometasone Furoate
administration, inhalation
mometasone
anti-inflammatory agents
anti-asthmatic agents
asthma
insurance, health, reimbursement
adult
adolescent
treatment outcome
randomized controlled trials as topic
meta-analysis as topic
comparative study

---
http://www.lecrat.eu/?s=Mom%C3%A9tasone
2007
false
France
French
Adrenocortical steroid therapy
Glucocorticoid therapy
corticosteroid therapy
Mometasone Furoate
anti-inflammatory agents
glucocorticoids
pregnancy
breast feeding
mometasone
mometasone furoate monohydrate
administration, intranasal
drug information

---
http://www.fmoq.org/Lists/FMOQDocumentLibrary/fr/Le%20M%C3%A9decin%20du%20Qu%C3%A9bec/Archives/2000%20-%202009/023-027InfoPoems0107.pdf
2007
false
false
Canada
French
corticosteroid therapy
antibiotic therapy
Celecoxib
Mometasone Furoate
rhinitis
sinusitis
administration, intranasal
anti-inflammatory agents
cyclooxygenase 2 inhibitors
naproxen
proton pump inhibitors
drug therapy, combination
peptic ulcer
colorectal neoplasms
colorectal neoplasms
dietary fiber
anti-bacterial agents
otitis media
patient participation
parents
Evidence-Based medicine
treatment outcome
breast neoplasms
estrogen replacement therapy
postmenopause
breast neoplasms
incidence
risk factors
critical appraisal or critical reading
Rhinosinusitis

---
Nous contacter.
24/04/2025


[Home] [Top]

© Rouen University Hospital. Any partial or total use of this material must mention the source.